[This corrects the article DOI: 10.18632/oncotarget.2340.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980629 | PMC |
| http://dx.doi.org/10.18632/oncotarget.27373 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Author Correction: On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
Sci Rep
June 2024
Center for Clinical Medicine Research, The First People's Hospital of Yunnan Province (Affiliated Hospital of Kunming University of Science and Technology), Kunming, 650032, China.
Author Correction: Wogonin suppresses osteopontin expression in adipocytes by activating PPARα.
Acta Pharmacol Sin
June 2023
Department of Pathophysiology, Wuhan University School of Basic Medical Sciences, Wuhan, 430071, China.
Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity Activation of TRKB Signaling in ΔK280 Tau-DsRed SH-SY5Y Cells.
Front Aging Neurosci
December 2021
Department of Life Science, National Taiwan Normal University, Taipei, Taiwan.
Alzheimer's disease (AD) is a progressive neurodegenerative disease with memory loss and cognitive decline. Neurofibrillary tangles (NFTs) formed by hyperphosphorylated Tau protein are one of the pathological hallmarks of several neurodegenerative diseases including AD. Heat shock protein family B (small) member 1 (HSPB1) is a molecular chaperone that promotes the correct folding of other proteins in response to environmental stress.
View Article and Find Full Text PDFAuthor Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation.
Sci Rep
June 2021
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells.
Oncotarget
January 2020
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, People's Republic of China.
[This corrects the article DOI: 10.18632/oncotarget.2340.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!